References
- Phillips‐Howard P A, Björkman A. Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs. Bull WHO 1990; 68: 493–504
- Edeson J FB, Field J W. Proguanil‐resistant falciparum malaria in Malaya. Br Med J 1950; 1: 147–151
- Wilson T, Munro D S, Richard D R. Proguanil‐resistance in Malayan strains of Plasmodium vivax. Br Med J 1952; 1: 564–568
- Worsley D E. Plasma paludrine levels‐ some observations in Commonwealth troops in Far East 1970. J R Army Med Corps 1985; 131: 148–151
- Björkman A, Phillips‐Howard P A. The epidemiology of drug‐resistant malaria. Trans R Soc Trop Med Hyg 1990; 84: 177–180
- WHO. Development of recommendations for the protection of short‐stay travellers to malaria endemic areas. Memorandum from two WHO Meetings. Bull WHO, 1987; 66: 177–196
- Bradley D J, Phillips‐Howard P A. Prophylaxis against malaria for travellers from the United Kingdom. Br Med J 1989; 2: 1087–1089
- Dukes M NG. Meyler's side‐effects of drugs11th ed. Elsevier, Amsterdam 1988; 588
- Fairley N H. Researches on paludrine (M 4888) in malaria. An experimental investigation undertaken by the LHQ medical research unit (AIF), Cairns, Australia. Trans R Soc Trop Med Hyg 1946; 40: 106–162
- Mulley G. Proguanil and mouth ulcers. Lancet 1974; 2: 177
- Daniels A M. Mouth ulceration associated with proguanil. Lancet 1986; 1: 269
- McD Davidson N. Mouth ulcer associated with proguanil. Lancet 1986; 1: 384
- Drysdale S F, Phillips‐Howard P A, Behrens R H. Proguanil, chloroquine and mouth ulcers. Lancet 1990; 1: 164
- Hanson S N, Kuylen K, Björkman A. Hairloss and scaling with proguanil. Lancet 1989; 1: 225
- Gon F, Reid F P. A case of recurrent subacute disseminated intravascular coagulation associated with malarial prophylaxis. S Afr Med J 1975; 49: 120–122
- Boots M, Philips M, Curtis J R. Megaloblastic anemia and pancytopenia due to proguanil in patients with renal failure. Clin Nephrol 1982; 18: 106–108
- Tattersall J E, Greenwood R N, Baker L RI, Cattel W R. Proguanil poisoning in a hemodialysis patient. Clin Nephrol 1987; 28: 104
- Phillips‐Howard P A, West L. Serious adverse reactions to pyrimethamine/sulphadoxine, pyrimethamine/dapsone and to amodiaquine in Britain. J R Soc Med 1990; 83: 82–85
- Keisu M, Öst Å. Diagnoses in patients with severe pancytopenia suspected of having aplastic anemia. Eur J Haematol 1990; 45: 11–14
- James D, Gilles H M. Human antiparasitic drugs: Pharmacology and usage. John Wiley o. Sons, Chichester 1985; 152
- Björkman A B, Phillips‐Howard P A. Adverse drug reactions to sulfa drugs; implications for malaria chemotherapy. Bull WHO.